BioSenic S.A.
BIOS.BR · BRU
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.00 | -0.00 | 0.00 |
| FCF Yield | 0.00% | 0.00% | -2,527.66% | -16.69% |
| EV / EBITDA | -30.94 | -5.29 | -72.05 | -12.42 |
| Quality | ||||
| ROIC | 14.48% | -399.06% | -14.43% | -59.70% |
| Gross Margin | 0.00% | 0.00% | 100.00% | -49.44% |
| Cash Conversion Ratio | 0.26 | -1.71 | 0.19 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | 42.14% | 45.09% | 47.29% | -20.55% |
| Free Cash Flow Growth | 0.00% | 100.00% | 44.63% | 21.88% |
| Safety | ||||
| Net Debt / EBITDA | -28.72 | -4.95 | -71.96 | -9.36 |
| Interest Coverage | -102.25 | -3.55 | -0.59 | -0.34 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -2,165.50 | -1,047.14 |